Biosyntia closes 1.5 million EUR round to launch world’s first bio-based vitamin B7
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
Medicfibers in collaboration with AIIMS New Delhi, has developed an antimicrobial solution Viroclog that when applied as a coating on textiles, provides long-lasting protection against HAI by reducing virus, bacteria, fungi survival on fabric
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Govt committed to supporting pharma companies with industry-friendly policies
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Strengthens investment in channels of the future to expand patient reach
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Subscribe To Our Newsletter & Stay Updated